Executive Director, GCS Kidney — POVE
Vertex Pharmaceuticals - Boston, MA
Posted Nov 15, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Offered From the posting source checked Nov 17, 2026
- Verification
- Not verified
- Salary
- $261K-$391K From the posting source checked Nov 17, 2026
- 401(k) match
- Not verified
Was this benefit information wrong? Tell us.
Role
- Seniority
- Director Plus From the posting source checked Nov 17, 2026
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Company
- Equity
- Offered Verified - SEC 10-K source checked Nov 17, 2026
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Executive Director, GCS Kidney — POVE Boston, MA Job Description General Summary: The Executive Director, Global Commercial Strategy (GCS) Kidney - Pove will be the senior commercial leader for povetacicept across the kidney indications, including immunoglobulin A nephropathy (IgAN) and primary membranous nephropathy (pMN). The role will own the global commercial strategy for the kidney franchise, supporting the near-term U.S. launch and subsequent global launches in IgAN while advancing pMN toward commercialization. The Executive Director will co-lead the povetacicept Kidney Program Team with the Development Lead, guiding program strategy and key development, lifecycle, and investment decisions. The role will lead global launch execution and lifecycle management in IgAN and build the global commercialization and launch strategy for pMN. Key Duties & Responsibilities Co-lead the povetacicept Kidney Program Team with the Development Lead, setting the integrated strategy, priorities, and decision framework across IgAN and pMN. Own the global commercial strategy for povetacicept in kidney, connecting launch, lifecycle, development, evidence, and investment priorities across the franchise. Lead GCS support for the U.S. IgAN launch and subsequent global launches, ensuring clear strategy, critical success factors, regional alignment, readiness, and execution. Own global lifecycle management for povetacicept in IgAN, identifying and advancing opportunities to strengthen differentiation, expand patient impact, generate evidence, and maximize long-term value. Lead the global commercialization and launch strategy for pMN, including market development, positioning, target product profile, evidence needs, value proposition, launch sequencing, and readiness. Shape development plans and lead commercial development activities across IgAN and pMN, including market research,
Read the full description at vrtx.wd501.myworkdayjobs.com. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
Senior Director, US Market Access Strategy, Povetacicept (POVE)
Vertex Pharmaceuticals - Boston, MA
Medical Director, Global Medical Affairs, Nephrology
Biogen - Cambridge, MA
National Head of OCS Kidney Program
Transmedics Group Inc - Andover, MA
Senior Director, Pipeline Market Access Strategy - Specialty, Obesity & Eye Care
AbbVie Inc. - Florham Park, NJ, United States